Ex vivo expansion of umbilical cord blood

References

• Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109–13
   PubMed Web of Science ®Google Scholar
• Cohen Y, Kreiser D, Mayorov M, et al. Unrelated and related cord blood banking and hematopoietic graft engineering. Cell Tissue Bank 2003; 4: 29–35
   Google Scholar
• Cohen Y, Nagler A. Umbilical cord blood transplantation: how, when and for whom?. Blood Rev 2004; 18: 167–79
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–66
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Gluckman E, Auerbach A, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990; 8(suppl 1)76–89
   PubMedGoogle Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–32
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–22
   PubMed Web of Science ®Google Scholar
• Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–22
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001; 5: 87–99
   PubMedGoogle Scholar
• Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397–407
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–77
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373–81
   PubMed Web of Science ®Google Scholar
• Weinreb S, Delgado JC, Clavijo OP, et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 1998; 22: 193–6
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 1870–1
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, Defor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915–9
   PubMed Web of Science ®Google Scholar
• de Lima M, St John LS, Wieder ED, et al. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 2002; 119: 773–6
   PubMed Web of Science ®Google Scholar
• Fernandez MN, Regidor C, Cabrera R, et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 2001; 28: 355–63
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368–76
   PubMed Web of Science ®Google Scholar
• Pecora AL, Stiff P, Jennis A, et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25: 797–9
   PubMed Web of Science ®Google Scholar
• Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase I trial using the AastromReplicell System. Blood 2003; 101: 5061–7
   PubMed Web of Science ®Google Scholar
• Pecora AL, Stiff P, LeMaistre CF, et al. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 295–303
   Google Scholar
• McNiece I, Jones R, Bearman SI, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001–7
   PubMed Web of Science ®Google Scholar
• McNiece I, Jones R, Cagnoni P, et al. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther 1999; 41: 82–6
   PubMedGoogle Scholar
• Purdy MH, Hogan CJ, Hami L, et al. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother 1995; 4: 515–25
   PubMedGoogle Scholar
• Guenechea G, Gan OI, Dorrell C, et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001; 2: 75–82
   PubMed Web of Science ®Google Scholar
• Lemischka IR, Jordan CT. The return of clonal marking sheds new light on human hematopoietic stem cells. Nat Immunol 2001; 2: 11–2
   Google Scholar
• Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci USA 2002; 99: 413–8
   PubMed Web of Science ®Google Scholar
• Summers YJ, Heyworth CM, de Wynter EA, et al. AC133+ G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplification of colony-forming cells in vitro. Stem Cells 2004; 22: 704–15
   PubMed Web of Science ®Google Scholar
• Summers YJ, Heyworth CM, de Wynter EA, et al. Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cells. Stem Cells 2001; 19: 505–13
   PubMed Web of Science ®Google Scholar
• Williams DA. Ex vivo expansion of hematopoietic stem and progenitor cells: robbing Peter to pay Paul?. Blood 1993; 81: 3169–72
   PubMed Web of Science ®Google Scholar
• McNiece IK, Almeida-Porada G, Shpall EJ, et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002; 30: 612–6
   PubMed Web of Science ®Google Scholar
• Von Drygalski A, Alespeiti G, Ren L, et al. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev 2004; 13: 101–11
   PubMed Web of Science ®Google Scholar
• Holyoake TL, Alcorn MJ, Richmond L, et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997; 19: 1095–101
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736–49
   PubMed Web of Science ®Google Scholar
• Lewis ID, Almeida-Porada G, Du J, et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001; 97: 3441–9
   PubMed Web of Science ®Google Scholar
• Guenechea G, Segovia JC, Albella B, et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999; 93: 1097–105
   PubMed Web of Science ®Google Scholar
• Zhai QL, Qiu LG, Li Q, et al. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Haematologica 2004; 89: 265–73
   Google Scholar
• Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000; 96: 4185–93
   PubMed Web of Science ®Google Scholar
• Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 1999; 94: 2161–8
   PubMed Web of Science ®Google Scholar
• Gammaitoni L, Weisel KC, Gunetti M, et al. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 2004; 103: 4440–8
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Garetto L, et al. The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors. Stem Cells 1998; 16(suppl 2)243–8
   Google Scholar
• Piacibello W, Sanavio F, Severino A, et al. Ex vivo expansion of cord blood progenitors. Vox Sang 1998; 74(suppl 2)457–62
   Google Scholar
• Murray LJ, Young JC, Osborne LJ, et al. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division. Exp Hematol 1999; 27: 1019–28
   PubMed Web of Science ®Google Scholar
• Young JC, Bruno E, Luens KM, et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+ Lin-primitive progenitor cells. Blood 1996; 88: 1619–31
   PubMed Web of Science ®Google Scholar
• Lazzari L, Lucchi S, Montemurro T, et al. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood. Bone Marrow Transplant 2001; 28: 693–8
   PubMedGoogle Scholar
• Lazzari L, Lucchi S, Porretti L, et al. Comparison of different serum-free media for ex vivo expansion of HPCs from cord blood using thrombopoietin, Flt-3 ligand, IL-6, and IL-11. Transfusion 2001; 41: 718–9
   Google Scholar
• Lazzari L, Lucchi S, Rebulla P, et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol 2001; 112: 397–404
   PubMed Web of Science ®Google Scholar
• Filip S, Vavrova J, Vokurkova D, et al. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients. Neoplasma 2000; 47: 73–80
   Google Scholar
• Vavrova J, Filip S, Vokurkova D, et al. Ex vivo expansion CD34+/AC133+-selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. Hematol Cell Ther 1999; 41: 105–12
   Google Scholar
• McNiece I, Kubegov D, Kerzic P, et al. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000; 28: 1181–6
   PubMed Web of Science ®Google Scholar
• Piacibello W, Sanavio F, Garetto L, et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998; 12: 718–27
   PubMed Web of Science ®Google Scholar
• Yao CL, Chu IM, Hsieh TB, et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol 2004; 32: 720–7
   PubMed Web of Science ®Google Scholar
• Peled T, Landau E, Mandel J, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32: 547–55
   PubMed Web of Science ®Google Scholar
• Peled T, Mandel J, Goudsmid NR, et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 2004; 6: 344–55
   PubMed Web of Science ®Google Scholar
• Peled T, Landau E, Prus E, et al. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol 2002; 116: 655–61
   PubMed Web of Science ®Google Scholar
• Young J.C, Wu S, Hansteen G, et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy 2004; 6: 328–36
   PubMed Web of Science ®Google Scholar
• Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004; 10: 55–63
   PubMed Web of Science ®Google Scholar
• Schofield R. The stem cell system. Biomed Pharmacother 1983; 37: 375–80
   PubMed Web of Science ®Google Scholar
• Lemischka IR, Moore KA. Stem cells: interactive niches. Nature 2003; 425: 778–9
   PubMed Web of Science ®Google Scholar
• Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004; 116: 769–78
   PubMed Web of Science ®Google Scholar
• Allen TD, Dexter TM. The essential cells of the hemopoietic microenvironment. Exp Hematol 1984; 12: 517–21
   PubMed Web of Science ®Google Scholar
• Allen TD, Simons PJ, Dexter TM. Haemopoietic microenvironments in vitro: which cells are involved?. Blood Cells 1984; 10: 467–71
   Google Scholar
• Chang J, Allen TD, Dexter TM. Long-term bone marrow cultures: their use in autologous marrow transplantation. Cancer Cells 1989; 1: 17–24
   PubMedGoogle Scholar
• Dexter TM, Allen TD, Lajtha LG, et al. Stimulation of differentiation and proliferation of haemopoietic cells in vitro. J Cell Physiol 1973; 82: 461–73
   PubMed Web of Science ®Google Scholar
• Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335–44
   PubMed Web of Science ®Google Scholar
• Dexter TM, Coutinho LH, Spooncer E, et al. Stromal cells in haemopoiesis. Ciba Found Symp 1990; 148: 76–86
   PubMedGoogle Scholar
• Moore MA, Sheridan AP, Allen TD, et al. Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment. Blood 1979; 54: 775–93
   Google Scholar
• Roberts RA, Spooncer E, Parkinson EK, et al. Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol 1987; 132: 203–14
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Roberts RA, Spooncer E, et al. Cellular interactions between 3T3 cells and interleukin-3-dependent multipotent haemopoietic cells: a model system for stromal-cell-mediated haemopoiesis. J Cell Physiol 1989; 139: 301–12
   PubMed Web of Science ®Google Scholar
• Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 1980; 77: 4756–9
   PubMed Web of Science ®Google Scholar
• Hackney JA, Charbord P, Brunk BP, et al. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 2002; 99: 13061–6
   Google Scholar
• Etheridge SL, Spencer GJ, Heath DJ, et al. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004; 22: 849–60
   PubMed Web of Science ®Google Scholar
• Kadereit S, Deeds LS, Haynesworth SE, et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(–) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 2002; 20: 573–82
   PubMed Web of Science ®Google Scholar
• Rattis FM, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr Opin Hematol 2004; 11: 88–94
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836–41
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Haynesworth SE, et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000; 9: 841–8
   PubMedGoogle Scholar
• Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57–66
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li C, Jiang X, et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004; 32: 657–64
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Hirayama F, Wakamoto S, et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion 2002; 42: 921–7
   PubMedGoogle Scholar
• Yamaguchi M, Hirayama F, Murahashi H, et al. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy 2002; 4: 109–18
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Hirayama F, Kanai M, et al. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol 2001; 29: 174–82
   PubMed Web of Science ®Google Scholar
• Kanai M, Hirayama F, Yamaguchi M, et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity. Bone Marrow Transplant 2000; 26: 837–44
   PubMed Web of Science ®Google Scholar
• McNiece I, Harrington J, Turney J, et al. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 2004; 6: 311–7
   PubMed Web of Science ®Google Scholar
• in 't Anker PS, Noort WA, Kruisselbrink AB, et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2003; 31: 881–9
   PubMed Web of Science ®Google Scholar
• in 't Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003; 88: 845–52
   PubMedGoogle Scholar
• in 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548–9
   PubMed Web of Science ®Google Scholar
• Ahrens N, Tormin A, Paulus M, et al. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 2004; 78: 925–9
   PubMedGoogle Scholar
• Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121: 368–74
   PubMed Web of Science ®Google Scholar
• Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870–8
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Gotherstrom C, et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004; 60: 307–15
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–41
   PubMed Web of Science ®Google Scholar
• Gotherstrom C, Ringden O, Tammik C, et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004; 190: 239–45
   PubMedGoogle Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5: 485–9
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208–13
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890–6
   PubMed Web of Science ®Google Scholar
• Gotherstrom C, Ringden O, Westgren M, et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 2003; 32: 265–72
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20
   PubMed Web of Science ®Google Scholar
• De Angeli S, Di Liddo R, Buoro S, et al. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med 2004; 13: 363–71
   Google Scholar
• Emerson SG, Palsson BO, Clarke MF, et al. In vitro expansion of hematopoietic cells for clinical application. Cancer Treat Res 1995; 76: 215–23
   Google Scholar
• Van Zant G, Rummel SA, Koller MR, et al. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells 1994; 20: 482–90
   PubMedGoogle Scholar
• Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993; 82: 378–84
   PubMed Web of Science ®Google Scholar
• Koller MR, Manchel I, Newsom BS, et al. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother 1995; 4: 159–69
   PubMedGoogle Scholar
• Koller MR, Manchel I, Maher RJ, et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998; 21: 653–63
   PubMed Web of Science ®Google Scholar